DA32 Life Science Tech Acquisition Corp.

DA32 Life Science Tech Acquisition Corp. (NASDAQ: DALS) was a blank-check company formed to pursue a business combination in the life sciences and technology sectors. The SPAC completed its initial public offering in 2022 and traded on the Nasdaq Capital Market under the ticker DALS. On August 8, 2023, the company filed a Form 15-12G with the SEC, a certification of termination of registration under Section 12(g) of the Securities Exchange Act of 1934, indicating that DALS concluded its SPAC lifecycle without completing a qualifying business combination and subsequently wound down operations. The vehicle targeted opportunities at the intersection of life sciences, healthcare technology, and innovation. Visit SpacDesk and sign up for full access to DALS filing history, sponsor details, timeline analytics, and the complete universe of SPAC data.